Canada markets open in 2 hours 24 minutes

Forte Biosciences, Inc. (FBRX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.7250+0.0087 (+1.21%)
At close: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
4,458
21,862
5,594
13,853
10,004
Selling General and Administrative
7,798
10,624
8,302
7,633
4,221
Total Operating Expenses
12,256
32,486
13,896
21,486
14,225
Operating Income or Loss
-12,256
-32,486
-13,896
-21,486
-14,225
Total Other Income/Expenses Net
-87
-114
-145
-222
-32,262
Income Before Tax
-12,343
-31,476
-13,879
-21,708
-46,487
Income from Continuing Operations
-12,343
-31,476
-13,879
-21,708
-46,487
Net Income
-12,343
-31,476
-13,879
-21,708
-46,487
Net Income available to common shareholders
-12,343
-31,476
-13,879
-21,708
-46,487
Basic EPS
-0.38
-1.00
-0.80
-1.55
-6.32
Diluted EPS
-0.38
-1.00
-0.80
-1.55
-6.32
Basic Average Shares
10,800
31,571
17,384
13,968
7,359
Diluted Average Shares
10,800
31,571
17,384
13,968
7,359